Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
Latest Information Update: 28 May 2024
At a glance
- Drugs Etanercept (Primary) ; Vedolizumab (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics
- Acronyms COBRA
Most Recent Events
- 23 May 2024 Status changed from recruiting to completed.
- 21 Jul 2022 Planned initiation date changed from 1 Apr 2022 to 1 Aug 2022.
- 21 Jul 2022 Status changed from not yet recruiting to recruiting.